Name:
Dr Leigh Stoddart FBPhS
Organisation:
Excellerate Bioscience
Year elected:
2023
Primary professional setting:
Industry
Leigh completed her CASE PhD in molecular pharmacology on the then newly deorphansied free fatty acid G protein-coupled receptors (GPCRs) at the University of Glasgow, under the supervision of Prof Graeme Milligan. In 2009 she joined Prof Steve Hill and Dr Steve Briddon’s group within the Institute of Cell Signalling at the University of Nottingham. During her time in Nottingham, she was central to the development and application of fluorescent ligand technology. These technologies have been widely adopted by molecular pharmacologists. She is the co-author on over 40 scientific publications, including high profile papers on the kinetics of ligands binding to GPCRs. In 2021, Leigh joined Excellerate Bioscience where she continues to apply her expertise in fluorescent ligand technology and pharmacology to advance their client’s drug discovery programmes.